Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors.


Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 19 09 2018
revised: 16 10 2018
accepted: 05 11 2018
pubmed: 7 12 2018
medline: 18 10 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

The Aurora kinases are a family of serine/threonine kinases that interact with components of the mitotic apparatus and serve as potential therapeutic targets in oncology. Herein, we reported a series of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl with selective inhibition of Aurora A in either enzymatic assays or cellular phenotypic assays, and displaying more potent anti-proliferation compared with that of VX-680. The most potent compound 10a forms better interaction with Aurora A than Aurora B in molecular docking. Mechanistic studies revealed that 10a disrupt the spindle formation, block the cell cycle progression in the G2/M phase and induce apoptosis in HeLa cell. These results suggested that the produced series of compounds are potential anticancer agents for further development as selective Aurora A inhibitors.

Identifiants

pubmed: 30502115
pii: S0968-0896(18)31634-1
doi: 10.1016/j.bmc.2018.11.006
pii:
doi:

Substances chimiques

Aniline Compounds 0
Cyclic N-Oxides 0
Piperidines 0
Protein Kinase Inhibitors 0
Pyrimidines 0
Aurora Kinase A EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-78

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Chun-Yan Sang (CY)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Wen-Wen Qin (WW)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Xiu-Juan Zhang (XJ)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Yu Xu (Y)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

You-Zhen Ma (YZ)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Xing-Rong Wang (XR)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China.

Ling Hui (L)

Experimental Center of Medicine, General Hospital of Lanzhou Military Command, Lanzhou 730050, China.

Shi-Wu Chen (SW)

School of Pharmacy, Lanzhou University, Lanzhou 730000, China. Electronic address: chenshw@lzu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH